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Nephronectin (NPNT) is an extracellular matrix (ECM) protein involved
in kidney development. We recently reported intracellular NPNT as a
potential prognostic marker in breast cancer and that NPNT promotes
metastasis in an integrin-dependent manner. Here, we used reverse-phase
protein array (RPPA) to analyze NPNT-triggered intracellular signaling in
the 66cl4 mouse breast cancer cell line. The results showed that the inte-
grin-binding enhancer motif is important for the cellular effects upon
NPNT interaction with its receptors, including phosphorylation of p38
mitogen-activated protein kinase (MAPK). Furthermore, analysis using
prediction tools suggests involvement of NPNT in promoting cell viability.
In conclusion, our results indicate that NPNT, via its integrin-binding
motifs, promotes cell viability through phosphorylation of p38 MAPK.
The cell–extracellular matrix (ECM) interaction plays a
vital role in tissue homeostasis, as well as in determining
the fate of cancer cells [1]. The composition of the ECM
and competitive binding among integrins determines
whether cells survive, differentiate, proliferate, migrate,
or influence shape and cell polarity (reviewed in [2–4]).
Integrins are transmembrane receptors well known for
their ability to link ECM ligands to the cytoskeleton
and transduce signals, which effects cellular responses.
Several integrins (a8b1, aVb3, aVb5, aVb6, and a4b7)
are shown to bind to NPNT [5,6], where some are
known to bind the common RGD (Arg-Gly-Asp) inte-
grin-binding motif [2]. NPNT contains an additional
integrin-binding motif, known as the EIE (Glu-Ile-Glu)
enhancer motif, located downstream of the RGD motif
and known to interact mainly with integrin a8b1 [7,8].
ECM–integrin interactions are known to influence
breast cancer progression, and altered expression of
integrins may predict poor survival in breast cancer
[9,10]. Also, in breast cancer tissues the expression of
ECM components is often elevated compared to normal
tissues [11]. High expression levels of NPNT have been
linked to the metastatic propensity of mouse breast can-
cer cells in a model of spontaneous metastasis [12]. In a
different syngeneic mouse model of breast cancer,
higher levels of NPNT were reported in metastatic
mammary tumor cells compared to nonmetastatic cells
[13]. Our recent results show that NPNT overexpressing
66cl4 cells (66cl4-NPNT) have an increased ability to
form lung metastases compared to 66cl4-empty vector
cells (66cl4-EV) in an experimental metastasis assay. A
single point mutation of the RGD motif alone (66cl4-
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RGE) was not sufficient to reduce the number of
NPNT-induced metastatic lesions. However, tumor bur-
den was significantly reduced in mice injected with cells
overexpressing NPNT mutated in both the RGD and
enhancer EIE motif (66cl4-RGE-AIA). This highlights
the importance of NPNT–integrin interaction in the for-
mation of lung metastasis [14]. The current study aimed
to investigate the biological function of NPNT in the
66cl4 cell line. We performed a comprehensive analysis
using reverse-phase protein array (RPPA) to further
identify molecular signals triggered by the NPNT–inte-
grin interaction. Using in vitro assays, we confirm the
involvement of NPNT in promoting cell viability.
Materials and methods
Cell culture
As described previously, 66cl4 cells were stably transduced
to overexpress NPNT or NPNT mutants (RGE or RGE-
AIA), while 66cl4 empty vector cells (EV) were used as a
control [14]. Furthermore, shRNA was used to knock
down NPNT protein levels in 4T1 cells (sh-NPNT), while a
nontargeting shRNA in 4T1 cells was used as a control
(sh-ctr) [14]. All cell lines were cultured in (1X) minimum
essential medium a (Thermo Fisher Scientific, Cat:
22561021), supplemented with 10% fetal bovine serum, 1%
(v/v) penicillin–streptomycin, and 1M hepes buffer (Thermo
Fisher Scientific, Cat: 15630080). Cell lines were routinely
tested for mycoplasma infection.
Immunofluorescence
66cl4-EV and 66cl4-NPNT were cultured for 24 h in
serum-free medium to evaluate the cell surface localization
of NPNT. 66cl4-EV cells were used as negative control.
The effect of incubating 66cl4-EV cells with 2 lgmL1
recombinant mouse NPNT (rmNPNT) (R&D systems,
Minneapolis, MN, USA; Cat: 4298-NP-050) in PBS for 1 h
prior fixing was also investigated. Cells were fixed with 4%
paraformaldehyde (PFA). Permeabilization of cells was
avoided to visualize extracellular NPNT. Anticollagen V
(Abcam, Cambridge, MA, USA; Cat: ab7046) was used as
a positive control. NPNT was identified with anti-NPNT
(Abnova, Taipei, Taiwan; Cat: PAB8467) (1 : 150) and
Alexa Fluor 488 as secondary antibody (Abcam, Cat:
ab150077) (1 : 1000). Images were captured using confocal
laser scanning microscope (Zeiss LSM 510 Meta, Oberko-
chen, Germany). Hoechst was used to stain the nucleus.
Reverse-phase protein array
66cl4-EV, 66cl4-NPNT, 66cl4-RGE, and 66cl4-RGE-AIA
cells were grown in serum-free medium for 24 h and then
collected at 80% confluency using a cell scraper and snap-
frozen in liquid nitrogen. To investigate the effect of
rmNPNT, 66cl4-EV cells were seeded on plates precoated
with 2 lglL1 rmNPNT in serum-free medium for 24 h.
Control plates were preincubated with PBS alone. Frozen
cell pellets (more than 1 million cells) were analyzed at the
MD Anderson Cancer Center, RPPA core facility, USA.
RPPA is high-throughput functional proteomics analysis
designed to analyze cellular protein activity in signaling
networks by measuring protein levels (both total and phos-
phorylated forms) using high-quality validated antibodies
[15,16]. Considering values from all four biological repli-
cates, the average signal intensity of proteins was calcu-
lated. Significant log-fold changes in protein expression
values in three different groups (‘NPNT vs EV’, ‘EVrmNPNT
vs EV’, and ‘RGE vs RGE-AIA’) were analyzed further.
Immunoblotting
The protein concentration of the whole-cell lysates was mea-
sured by Bio-Rad protein assay (Bio-Rad, Hercules, CA,
USA; Cat: 500-0006). A total of 50 lg protein was loaded in
NuPAGE Novex 10% (Invitrogen, Carlsbad, CA, USA;
Cat: NP0301BOX). Protein transferred to a PVDF mem-
brane was further incubated with primary antibodies: p38
MAPK (1 : 1000) (CST, Cat: 9212) and phospho-p38
MAPK (1 : 1000) (CST, Cat: 9211). Bound primary antibod-
ies were detected using an appropriate HRP-linked sec-
ondary antibody (Dako, Santa Clara, CA, USA; Cat: P0447
or P0399) and imaged using Supersignal West Femto sub-
strate (Pierce, Cat: 34096) with the Odyssey Fc system (Li-
Cor biosciences, Lincoln, NE, USA). Western blots were
quantified using IMAGE STUDIO 3.1 software (Li-Cor bio-
sciences). Statistical analyses were performed using two-
tailed Student’s t-tests assuming equal variance.
Ingenuity pathway analysis
Ingenuity pathway analysis (Qiagen, Hilden, Germany) is a
web-based program which uses algorithms to connect pro-
tein expression values to its corresponding biological
response. The RPPA analysis resulted in a list of differen-
tially expressed proteins (log-fold change) between the RGE
and RGE-AIA group, which was further analyzed by IPA to
identify the cellular function most likely to be affected by the
alteration in the NPNT enhancer motif. IPA bases its analy-
sis on already published information about protein net-
works. A stronger prediction (lower P-value) is made when
several proteins are present within the same pathway.
Cell viability assay
A total of 2500 cells per well were seeded in a 384-well plate
in serum-free medium for 24 h. Cells were lysed using the
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Cell Titer-Glo luminescent cell viability assay kit (Promega,
Madison, WI, USA; Cat: G7570). The end point of this assay
reports luminescence, which is proportional to ATP gener-
ated from cells surviving in serum-free medium. Cell viability
was also measured in 66cl4-EV cells when incubated with
serum-free medium supplemented with rmNPNT
(2 lgmL1). The p38 MAPK inhibitor BIRB 796 (Axon
Medchem, Groningen, Netherlands; Cat: 1358) was used at
4 lM, which was found to be the optimal concentration for
66cl4 and 4T1 cell lines. The p38 MAPK inhibitors
LY2228820 (Selleckchem, Munich, Germany; Cat: S1494)
and SB203580 (Selleckchem, Cat: S1076) were used at a con-
centration of 5 lM. The cells were grown in serum-free med-
ium and simultaneously exposed to the inhibitors for 24 h.
Results and Discussion
Cell surface distribution of NPNT in 66cl4 cells
Although NPNT is mostly documented to be an extracel-
lular protein [6,17,18], we have recently shown that
NPNT is localized intracellularly in the cytoplasm and
packed in vesicles/granules in breast cancer tissues and in
exosomes isolated from cell lines [14]. Our previous find-
ings showing an integrin-dependent metastasis-promot-
ing effect also suggest extracellular localization and
function of NPNT in breast cancer. To visualize the cell
surface distribution of NPNT in 66cl4 cells overexpress-
ing NPNT (66cl4-NPNT), we imaged the cells using
immunofluorescence microscopy (Fig. 1A). In this exper-
imental setup, without permeabilization of the cells, the
results showed an extracellular focal distribution of
NPNT. 66cl4-EV cells cultured in serum-free medium for
24 h were used as a negative control. Recombinant
NPNT (2 lgmL1) added to the 66cl4-EV cells for 1 h
prior to fixing could be detected in a similar location as
wild-type NPNT in 66cl4-NPNT cells. Collagens are
major constituents of ECM, and staining for collagen V
showed a similar pattern as staining for NPNT, further
demonstrating extracellular localization of NPNT in the
66cl4 cells. Using Z-stack images of the 66cl4-NPNT
cells, we plotted a Z profile showing the signal intensity
in the green (NPNT-Alexa 488) and blue (nucleus-
Hoechst) channels as a function of distance from the sur-
face of the culture dish (Fig. 1B). The graph shows that
the signal derived from NPNT is located below the
nucleus, close to the surface of the plate (Video S1). This
points to an extracellular localization of NPNT, as has
already been shown by others [6,17,18]. Seeding equal
numbers of 66cl4-EV cells on rmNPNT-coated plates
and uncoated plates showed that presence of rmNPNT
increased the proportion of cells that attached and spread
out compared to the uncoated plates where a large
number of cells still remained rounded at 24 h (Fig. 1C).
This is in line with our previous finding showing involve-
ment of NPNT in promoting cell adhesion [14].
RPPA analysis of NPNT-mediated signaling
Various ECM proteins contribute in establishing the
phenotype of mammary epithelial cells and can regu-
late tissue-specific function in an autocrine or para-
crine manner [19]. To elucidate the downstream
intracellular signaling effects of extracellular NPNT,
we used high-throughput RPPA functional proteomics
that allow the measurement of protein levels and rela-
tive amounts of phosphorylated proteins in several
samples using 300 different antibodies simultaneously
[20,21]. The signal intensity from protein–antibody
binding was quantified and used for data analysis. The
three circles in the Venn diagram represent (a) the
proteins regulated by seeding control cells (66cl4-EV)
on plates coated with rmNPNT (EVrmNPNT vs EV),
(b) the proteins regulated by the NPNT overexpres-
sion (NPNT vs EV), and (c) the proteins regulated by
the integrin-binding enhancer motif alone (RGE vs
RGE-AIA) (Fig. 2A/Table S1). The four proteins in
the overlap between these three comparisons were
identified as p38 MAPK, Src, Mnk1, and Rad51
(Fig. 2B) and may represent possible common players
of NPNT-induced signaling. Dual phosphorylation of
p38 MAPK at T180 and Y182 activates downstream
intracellular signals to regulate growth, differentiation,
survival, and respond to stress [22,23]. Src is a down-
stream effector in integrin signaling, and phosphoryla-
tion of Src at Y527 is usually transient and renders
the enzyme less active [24,25]. Rad51 is known for its
role in DNA repair [26]. Mnk1 acts downstream in
p38 MAPK signaling pathway [27]. The presence of
either wild-type NPNT or NPNT-RGE increased
phosphorylation of p38 MAPK (T180 and Y182) and
phosphorylation of Src (Y527), while the double
mutant of NPNT did not (Fig. 2B). Rad51 protein
levels increased when cells were seeded onto rmNPNT
or expressing either wild-type NPNT or NPNT-RGE,
while cells expressing NPNT with the double mutation
did not show any increase in Rad51 protein levels.
For Mnk1, the effect was opposite. Compared to
66cl4-EV control cells, Mnk1 protein levels were
reduced in cells seeded onto rmNPNT or expressing
either wild-type NPNT or NPNT carrying the RGD
mutation, while cells expressing NPNT mutated in
both the RGD and the enhancer motif EIE did not
display altered protein levels of Mnk1 (Fig. 2B). Sup-
pression of Mnk1 expression has been reported to
increase the eukaryotic transcription initiation factor
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4F activity (eIF4F) [28], a factor known to promote
survival of breast cancer cells [29]. Further studies are
required to identify the involvement of transcription
factors such as eIF4F, and apoptosis-regulating pro-
teins influenced by NPNT-induced signaling. The
RPPA analysis suggests that NPNT influences on the





Fig. 1. Cell surface distribution of NPNT in 66cl4 cells. (A) Immunofluorescence microscopy showing extracellular NPNT detected on 66cl4
cells expressing wild-type NPNT and 66cl4-EV cells when preincubated with rmNPNT for 1 h prior fixing. 66cl4-EV was used as a negative
control. Detection of collagen V on 66cl4-NPNT cells was used as a positive control. Primary antibodies were visualized with Alexa Fluor
488. Nucleus is stained blue with Hoechst. Scale bar 10 lm. (B) Z profile comparing the green and blue channels was calculated by
normalizing mean intensity per slice in the stack for each channel using the image of 66cl4 cells overexpressing NPNT shown above. (C)
Brightfield microscopy images of 66cl4-EV cells growing on uncoated plates (EV) in contrast to rmNPNT-coated plates (EVrmNPNT) at 24 h.
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total protein levels of Mnk1 and Rad51 and the phos-
phorylation status of p38 MAPK and Src. These
results also point to the importance of the integrin
enhancer motif in these regulatory processes.
NPNT promotes cell viability via its enhancer
motif
Ingenuity pathway analysis (IPA) can recognize the
RPPA protein signal intensities and correlate them to
their corresponding genes and then predict potential
downstream cellular functions. We have utilized the
dataset from the ‘RGE vs RGE-AIA’ group to specifi-
cally identify the molecular and cellular functions sup-
ported by the integrin-binding enhancer motif of
NPNT. Cell death and survival, cellular growth and
proliferation, and cellular development are some of the
top categories which were predicted to be influenced
by the NPNT enhancer motif (Table 1). In each of the
categories, we could investigate further the specific cel-
lular functions using the up- and downregulated pro-
teins expression values from the RGE vs RGE-AIA
group. There were 69 proteins pointing toward a role
of the NPNT enhancer motif in cell viability (Fig. 3
and Table 1). Rad51, p38 MAPK (shown as
MAPK14), Mnk1 (shown as MKNK1), and Src are
among those 69 proteins known to influence cell via-
bility (Fig. 3). In line with our results, NPNT has also
previously been reported involved in survival of osteo-
blasts [30]. NPNT is known to interact with integrin
a8b1 [8,31], and integrins activate survival pathways
via PI3K-kinase or MAPKs [3,32]. Phosphorylated
p38 MAPK can have a pleiotropic role, mediating
either cell survival or cell death depending on the cell
type, disease stage, and type of stimulus [33–35]. Acti-
vated p38 MAPK can phosphorylate various transcrip-
tion factors as well as antiapoptotic (Bcl-2) and
proapoptotic (Bad) proteins [36]. In breast cancer,
phosphorylated p38 MAPK has been linked to poor
outcomes [37]. Interestingly, interference with p38
MAPK signaling in cancer cells has been shown to
reduce the tumor-promoting capacities of the microen-
vironment [38] and to potentiate the effect of conven-
tional chemotherapies (reviewed in [39]), and was
therefore chosen for further analysis in this study.
Fig. 2. Reverse-phase protein array analysis of NPNT-mediated signaling. The Venn diagram includes number of proteins significantly regulated
and/or modified (P < 0. 05) in all four biological replicates. (A) The pink circle in the Venn diagram, ‘NPNT vs EV’, denotes the log-fold change
values triggered in 66cl4-NPNT cells in comparison with 66cl4-EV cells. The blue circle, ‘EVrmNPNT vs EV’, represents 66cl4-EV cells cultured on
rmNPNT (EVrmNPNT) in comparison with 66cl4-EV cells seeded in noncoated wells. The purple circle represents proteins regulated by the
integrin-binding motifs of NPNT; the effect of a single mutation in the RGD motif (RGD ? RGE) versus mutations in both RGD and EIE motifs
(RGD-EIE -> RGE-AIA). (B) Box plot showing log2 protein abundance of the four overlapping proteins from the Venn diagram.
Table 1. Top predicted molecular and cellular functions. RPPA
results from RGE vs RGE-AIA group were analyzed using the web-
based software application ingenuity pathway analysis (IPA) tool to
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NPNT mediates cell viability via p38 signaling
pathways
Results from the RPPA and IPA analyses indicated
that NPNT and its integrin-binding motifs could be
involved in determining cell viability via p38 MAPK
phosphorylation in our study model. An in vitro cell via-
bility assay was used to analyze the different 66cl4 cells.
An increase in viability was seen when EV cells were
incubated with serum-free medium containing
rmNPNT, or when 66cl4 cells were overexpressing wild-
type NPNT. In cells where both integrin-binding motifs
were mutated (RGE-AIA), there was a reduction in via-
bility compared to cells overexpressing wild-type NPNT
(Fig. 4A/Dataset 1). Exposure of 66cl4-EV cells to
rmNPNT (EV rmNPNT) coating for 24 h in serum-free
media stimulated p38 MAPK phosphorylation com-
pared to control cells (Fig. S1a/Dataset 2), thus confirm-
ing the results obtained from RPPA. To further explore
the involvement of p38 MAPK in NPNT-induced via-
bility, we utilized the p38 MAPK inhibitor, BIRB 796,
known to inhibit all p38 MAPK isoforms in vitro [40].
The viability of control cells (EV) was unaffected by p38
MAPK inhibition, thereby excluding any off-target
effects that may interfere with viability in this particular
assay. On the other hand, a significant decrease in via-
bility was seen in both 66cl4-NPNT and 66cl4-NPNT-
RGE cells when phosphorylation of p38 MAPK was
inhibited using BIRB 796, while addition of BIRB 796
to cells carrying the double mutation (RGE-AIA) had
no statistically significant effect on cell viability. Similar
findings were obtained using the p38 MAPK inhibitors,
LY2228820 and SB203580, significantly reducing
NPNT-mediated cell viability (Fig. S2a/Dataset 3). This
indicates that p38 MAPK functions downstream of
NPNT and regulates viability of the 66cl4 cells. These
observations were further validated by comparing the
parental 66cl4 cells, with low endogenous NPNT, to the
parental 4T1 cells, with high endogenous NPNT levels
[12,14]. The 66cl4 cell line generally showed lower p38
MAPK phosphorylation compared to the 4T1 cells
(Fig. S1b/Dataset 2). When 4T1 cells were treated with
the p38 MAPK inhibitor, viability was markedly
reduced (Fig. 4B/Fig. S2b). 4T1 cells, expressing a non-
targeting shRNA (sh-ctr), responded similarly as the
4T1 parental cells. Next, we analyzed 4T1 cells with
Cell viability
Fig. 3. Nephronectin promotes cell viability via its enhancer motif. Representation of the 69 upregulated (red) or downregulated (green)
proteins (shown as gene symbols) identified by IPA to have a direct relationship with cell viability. The asterisk indicates that multiple
proteins in the dataset file map to a single gene.
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Fig. 4. Nephronectin mediates cell viability via p38 signaling pathways. (A) Indicated variants of 66cl4 cells were treated with () 4 lM p38
MAPK inhibitor (BIRB 796) for 24 h, in addition to serum deprivation. Where indicated, 66cl4-EV cells were stimulated by adding 2 lgmL1
rmNPNT to the cell culture medium. Cell viability was determined using CellTiter-Glo. (B) Viability of NPNT expressing, 4T1 cells with a NPNT-
targeted short hairpin (sh-NPNT) and a nontargeting shRNA (sh-ctr) was tested using CellTiter-Glo. Significance is tested using a two-tailed
Student’s t-test. *P < 0. 05, **P < 0. 005, ***P < 0. 0001. Error bars represent SD. N = number of independent experiments, n = total number
of replicates in each test group. (C) Illustration summarizing the cellular effects of integrin binding to wild-type or mutated NPNT via p38 MAPK.
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stable shRNA knock-down of NPNT, 4T1 (sh-NPNT)
[14]. The knock-down generally decreased the cell viabil-
ity of the 4T1 (sh-NPNT) cells compared to the parental
4T1 cells. Although treatment with the BIRB 796 did
not further decrease the viability (Fig. 4B/Dataset 1),
the LY2228820 and SB203580 inhibitors did reduce via-
bility in the 4T1 (sh-NPNT) cells (Fig. S2b/Dataset 3).
Taken together, these results demonstrate a role for
NPNT and its integrin-binding motifs, in particular the
EIE-enhancer motif, in the induction of p38 MAPK sig-
naling and cell viability. There are four members of the
p38 family (p38a, p38b, p38c, and p38d), of which p38a
(MAPK14) is best studied and expressed in most cell
types [41]. However, further investigation is needed to
elaborate on the role specific role of the different p38
isoforms. Results from the current study are summa-
rized in Fig. 4C and show that NPNT can activate p38
MAPK and by that promote viability in 66cl4 breast
cancer cells. The requirement of the NPNT EIE-enhan-
cer motif in the activation of p38 MAPK is a novel find-
ing, making this a potential drug target in tumors with
high NPNT expression. Interestingly, though the RGD
motif has shown great promise as a therapeutic target
[2], drugs such as cilengitide have failed in clinical trials
due to lack of efficiency [42]. Based on the current find-
ings, we therefore suggest that dual targeting of the
RGD and EIE-enhancer motif could prove to be more
efficient for cancers with high NPNT levels.
Acknowledgements
The study received funding from the Central Norway
Regional Health Authority (Project number:
46077600), North Norwegian Regional Health Author-
ities (Project number SFP1232-15) The Erna and Olav
Aakre Foundation for Cancer Research, The Blix
Family Fund for Medical Research, and UiT—The
Arctic University of Norway. We also acknowledge
services carried out at MD Anderson Cancer Center,
USA, funded by NCI # CA16672. Dr. Fred Miller
kindly provided 66cl4 and 4T1, mouse cell lines. We
express our gratitude to Dr. Naoko Morimura for the
pcDNA3-POEM-Fc vector and Dr. Peter McCourt for
linguistic revision. We appreciate the technical supervi-
sion received from Bjørnar Sporsheim and Kjartan
Wøllo Egeberg with handling of confocal microscope.
Author contributions
TSS and GS conceived and supervised the study. JT
and SNM designed the experiments. JT and KC per-
formed the experiments and analyzed the data. All
authors have contributed equally to writing of the
manuscript and revisions.
Conflict of interest
The authors declare no conflict of interest.
Data Accessibility
Research data pertaining to this article are located
at figshare.com: https://doi.org/10.6084/m9.figshare.
7270889.v1
Dataset 1: Raw data for Fig. 4; Dataset 2: Raw data
for Fig. S1; Dataset 3: Raw data for Fig. S2.
References
1 Dolberg DS, Hollingsworth R, Hertle M and Bissell MJ
(1985) Wounding and its role in RSV-mediated tumor
formation. Science (New York, NY) 230, 676–678.
2 Nieberler M, Reuning U, Reichart F, Notni J, Wester
HJ, Schwaiger M, Weinmuller M, Rader A, Steiger K
& Kessler H (2017) Exploring the role of RGD-
recognizing integrins in cancer. Cancers (Basel) 9, 116.
3 Stupack DG (2002) Get a ligand, get a life: integrins,
signaling and cell survival. J Cell Sci 115, 3729–3738.
4 Vachon PH (2011) Integrin signaling, cell survival, and
anoikis: distinctions, differences, and differentiation. J
Signal Transduct 2011, 738137.
5 Morimura N, Tezuka Y, Watanabe N, Yasuda M,
Miyatani S, Hozumi N and Tezuka Ki K (2001)
Molecular cloning of POEM: a novel adhesion molecule
that interacts with alpha8beta1 integrin. J Biol Chem
276, 42172–42181.
6 Brandenberger R, Schmidt A, Linton J, Wang D,
Backus C, Denda S, M€uller U and Reichardt LF (2001)
Identification and characterization of a novel
extracellular matrix protein nephronectin that is
associated with integrin a8b1 in the embryonic kidney.
J Cell Biol 154, 447–458.
7 Sanchez-Cortes J and Mrksich M (2011) Using self-
assembled monolayers to understand alpha8beta1-
mediated cell adhesion to RGD and FEI motifs in
nephronectin. ACS Chem Biol 6, 1078–1086.
8 Sato Y, Uemura T, Morimitsu K, Sato-Nishiuchi R,
Manabe R, Takagi J, Yamada M and Sekiguchi K
(2009) Molecular basis of the recognition of
nephronectin by integrin alpha8beta1. J Biol Chem 284,
14524–14536.
9 dos Santos PB, Zanetti JS, Ribeiro-Silva A and Beltrao
EI (2012) Beta 1 integrin predicts survival in breast
cancer: a clinicopathological and immunohistochemical
study. Diagnost Pathol 7, 104.
1999FEBS Open Bio 8 (2018) 1992–2001 ª 2018 The Authors. Published by FEBS Press and John Wiley & Sons Ltd.
J. Toraskar et al. Enhancer motif of NPNT promotes cell viability
10 Moore KM, Thomas GJ, Duffy SW, Warwick J, Gabe
R, Chou P, Ellis IO, Green AR, Haider S, Brouilette K
et al. (2014) Therapeutic targeting of integrin
alphavbeta6 in breast cancer. J Natl Cancer Inst. 106,
dju 169.
11 Insua-Rodriguez J and Oskarsson T (2016) The
extracellular matrix in breast cancer. Adv Drug Deliv
Rev 97, 41–55.
12 Eckhardt BL, Parker BS, van Laar RK, Restall CM,
Natoli AL, Tavaria MD, Stanley KL, Sloan EK,
Moseley JM and Anderson RL (2005) Genomic
analysis of a spontaneous model of breast cancer
metastasis to bone reveals a role for the extracellular
matrix. Mol Cancer Res 3, 1–13.
13 Borowsky AD, Namba R, Young LJ, Hunter KW,
Hodgson JG, Tepper CG, McGoldrick ET, Muller WJ,
Cardiff RD and Gregg JP (2005) Syngeneic mouse
mammary carcinoma cell lines: two closely related cell
lines with divergent metastatic behavior. Clin Exp
Metas 22, 47–59.
14 Steigedal TS, Toraskar J, Redvers RP, Valla M,
Magnussen SN, Bofin AM, Opdahl S, Lundgren S,
Eckhardt BL, Lamar JM et al. (2018) Nephronectin is
correlated with poor prognosis in breast cancer and
promotes metastasis via its integrin-binding motifs.
Neoplasia (New York, NY) 20, 387–400.
15 Hennessy BT, Lu Y, Gonzalez-Angulo AM, Carey
MS, Myhre S, Ju Z, Davies MA, Liu W, Coombes
K, Meric-Bernstam F et al. (2010) A technical
assessment of the utility of reverse phase protein
arrays for the study of the functional proteome in
non-microdissected human breast cancers. Clin
Proteomics 6, 129–151.
16 Ju Z, Liu W, Roebuck PL, Siwak DR, Zhang N, Lu Y,
Davies MA, Akbani R, Weinstein JN, Mills GB et al.
(2015) Development of a robust classifier for quality
control of reverse-phase protein arrays. Bioinformatics
(Oxford, England) 31, 912–918.
17 Sun Y, Kuek V, Qiu H, Tickner J, Chen L, Wang H,
He W and Xu J (2018) The emerging role of NPNT in
tissue injury repair and bone homeostasis. J Cell
Physiol 233, 1887–1894.
18 Kahai S, Lee SC, Lee DY, Yang J, Li M, Wang CH,
Jiang Z, Zhang Y, Peng C and Yang BB (2009)
MicroRNA miR-378 regulates nephronectin expression
modulating osteoblast differentiation by targeting
GalNT-7. PLoS One 4, e7535.
19 Barcellos-Hoff MH & Bissell MJ (1989) A role for the
extracellular matrix in autocrine and paracrine
regulation of tissue-specific functions. In Autocrine and
Paracrine Mechanisms in Reproductive Endocrinology
(Krey LC, Gulyas BJ & McCracken JA, eds), pp. 137–
155. Springer US, Boston, MA.
20 Akbani R, Becker KF, Carragher N, Goldstein T, de
Koning L, Korf U, Liotta L, Mills GB, Nishizuka SS,
Pawlak M et al. (2014) Realizing the promise of reverse
phase protein arrays for clinical, translational, and basic
research: a workshop report: the RPPA (Reverse Phase




22 Wilson KP, Fitzgibbon MJ, Caron PR, Griffith JP,
Chen W, McCaffrey PG, Chambers SP and Su MS
(1996) Crystal structure of p38 mitogen-activated
protein kinase. J Biol Chem 271, 27696–27700.
23 Cuadrado A and Nebreda AR (2010) Mechanisms and
functions of p38 MAPK signalling. Biochem J 429,
403–417.
24 Playford MP and Schaller MD (2004) The interplay
between Src and integrins in normal and tumor
biology. Oncogene 23, 7928–7946.
25 Zhang S and Yu D (2012) Targeting Src family kinases
in anti-cancer therapies: turning promise into triumph.
Trends Pharmacol Sci 33, 122–128.
26 Sung P, Krejci L, Van Komen S and Sehorn MG
(2003) Rad51 recombinase and recombination
mediators. J Biol Chem 278, 42729–42732.
27 Fukunaga R and Hunter T (1997) MNK1, a new MAP
kinase-activated protein kinase, isolated by a novel
expression screening method for identifying protein
kinase substrates. EMBO J 16, 1921–1933.
28 O’Loghlen A, Gonzalez VM, Salinas M and Martin
ME (2004) Suppression of human Mnk1 by small
interfering RNA increases the eukaryotic initiation
factor 4F activity in HEK293T cells. FEBS Lett 578,
31–35.
29 Wendel HG, De Stanchina E, Fridman JS, Malina A,
Ray S, Kogan S, Cordon-Cardo C, Pelletier J and
Lowe SW (2004) Survival signalling by Akt and eIF4E
in oncogenesis and cancer therapy. Nature 428, 332–
337.
30 Ikehata M, Yamada A, Morimura N, Itose M, Suzawa
T, Shirota T, Chikazu D and Kamijo R (2017) Wnt/beta-
catenin signaling activates nephronectin expression in
osteoblasts. Biochem Biophys Res Commun 484, 231–234.
31 Schnapp LM, Hatch N, Ramos DM, Klimanskaya IV,
Sheppard D and Pytela R (1995) The human integrin
alpha 8 beta 1 functions as a receptor for tenascin,
fibronectin, and vitronectin. J Biol Chem 270, 23196–
23202.
32 Farias E, Lu M, Li X and Schnapp LM (2005) Integrin
alpha8beta1-fibronectin interactions promote cell
survival via PI3 kinase pathway. Biochem Biophys Res
Commun 329, 305–311.
33 Koul HK, Pal M and Koul S (2013) Role of p38 MAP
kinase signal transduction in solid tumors. Genes
Cancer 4, 342–359.
34 Park JS, Carter S, Reardon DB, Schmidt-Ullrich R,
Dent P and Fisher PB (1999) Roles for basal and
2000 FEBS Open Bio 8 (2018) 1992–2001 ª 2018 The Authors. Published by FEBS Press and John Wiley & Sons Ltd.
Enhancer motif of NPNT promotes cell viability J. Toraskar et al.
stimulated p21(Cip-1/WAF1/MDA6) expression and
mitogen-activated protein kinase signaling in radiation-
induced cell cycle checkpoint control in carcinoma cells.
Mol Biol Cell 10, 4231–4246.
35 Reinhardt HC, Aslanian AS, Lees JA and Yaffe MB
(2007) p53-deficient cells rely on ATM- and ATR-
mediated checkpoint signaling through the p38MAPK/
MK2 pathway for survival after DNA damage. Cancer
Cell 11, 175–189.
36 Takeda K, Naguro I, Nishitoh H, Matsuzawa A and
Ichijo H (2011) Apoptosis signaling kinases: from stress
response to health outcomes. Antioxid Redox Signal 15,
719–761.
37 Esteva FJ, Sahin AA, Smith TL, Yang Y, Pusztai L,
Nahta R, Buchholz TA, Buzdar AU, Hortobagyi GN
and Bacus SS (2004) Prognostic significance of
phosphorylated P38 mitogen-activated protein kinase
and HER-2 expression in lymph node-positive breast
carcinoma. Cancer 100, 499–506.
38 Suarez-Cuervo C, Merrell MA, Watson L, Harris
KW, Rosenthal EL, Vaananen HK and Selander KS
(2004) Breast cancer cells with inhibition of
p38alpha have decreased MMP-9 activity and exhibit
decreased bone metastasis in mice. Clin Exp Metas
21, 525–533.
39 Igea A and Nebreda AR (2015) The stress kinase
p38alpha as a target for cancer therapy. Cancer Res 75,
3997–4002.
40 Kuma Y, Sabio G, Bain J, Shpiro N, Marquez R and
Cuenda A (2005) BIRB796 inhibits all p38 MAPK
isoforms in vitro and in vivo. J Biol Chem 280, 19472–
19479.
41 Cuenda A and Rousseau S (2007) p38 MAP-kinases
pathway regulation, function and role in human
diseases. Biochim Biophys Acta 1773, 1358–1375.
42 Stupp R, Hegi ME, Gorlia T, Erridge SC, Perry J,
Hong YK, Aldape KD, Lhermitte B, Pietsch T,
Grujicic D et al. (2014) Cilengitide combined with
standard treatment for patients with newly diagnosed
glioblastoma with methylated MGMT promoter
(CENTRIC EORTC 26071-22072 study): a multicentre,
randomised, open-label, phase 3 trial. Lancet Oncol 15,
1100–1108.
Supporting information
Additional supporting information may be found
online in the Supporting Information section at the end
of the article.
Fig. S1. Phosphorylation of p38 MAPK in the pres-
ence of NPNT (a) Immunoblotting for detecting phos-
phorylation levels of p38 MAPK using whole cell
lysates made of 66cl4-EV and 66cl4-EVrmNPNT. cul-
tured under serum-free conditions for 24 h. (b)
Immunoblotting for phospho-p38 MAPK and total-
p38 MAPK level using lysates from mother cell lines,
66cl4 and 4T1, grown on uncoated plates for 24 h in
serum-free conditions. Quantification of optical density
represents the mean of three independent experiments.
Significance is tested using a two tailed Student’s t-test
assuming equal variance. *P < 0.05, **P < 0.005,
***P < 0.0001. Error bars represent SD.
Fig. S2. NPNT mediates cell viability via p38 signaling
pathways (a) Indicated variants of 66cl4 cells were
treated with (+/) 5 lM p38 MAPK inhibitor
(LY2228820 or SB203580) for 24 h, in addition to
serum deprivation. Cell viability was determined using
CellTiter-Glo. (b) Viability of NPNT expressing, 4T1
cells with an NPNT-targeted short hairpin (sh-NPNT)
and a nontargeting shRNA (sh-ctr) was tested upon
incubating cells with (+/) 5 lM p38 MAPK inhibitor
(LY2228820 or SB203580) for 24 h. Significance is
tested using a two tailed Student’s t-test. *P < 0.05,
**P < 0.005, ***P < 0.0001. Error bars represent SD.
N = number of independent experiments, n = total
number of replicates in each test group.
Table S1. RPPA details. List of differentially expressed
proteins shown in the Venn diagram, Fig. 2a.
Video S1. Z-stack sections in 66cl4-NPNT cells were
compiled to visualize the signal for NPNT (green
channel). Each image in the section has a voxel depth
of 0.36 lm. Assuming the reflection coming from the
culture plate to be zero, we get the highest intensity
for NPNT-Alexa 488 at the 4th section. This means
we get the highest intensity signal for NPNT at 1.4 lm
(0.36*4).
2001FEBS Open Bio 8 (2018) 1992–2001 ª 2018 The Authors. Published by FEBS Press and John Wiley & Sons Ltd.
J. Toraskar et al. Enhancer motif of NPNT promotes cell viability
